Avita Medical (RCEL) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Avita Medical (RCEL) has outperformed Viemed Healthcare (VMD) over the past year, gaining 138.6% versus a gain of 36.4%. Over five years, VMD leads with a +62.4% price change compared with -24.9% for RCEL. Avita Medical is the larger company by market cap ($401.9 million vs $365.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RCEL | VMD |
|---|---|---|
| Share price | $13.00 | $9.60 |
| Market cap | $401.89M | $365.65M |
| 1-day change | -0.42% | +2.45% |
| YTD return | +278.26% | +26.11% |
| 1-year return | +138.57% | +36.39% |
| 5-year return | -24.87% | +62.39% |
| P/E ratio (TTM) | — | 26.67 |
| Forward P/E | — | 24.00 |
| EPS (TTM) | $-1.43 | $0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $12.61 |
| 52-week low | $3.22 | $6.05 |
| Distance from 52-week high | -3.74% | -23.87% |
| Analyst consensus | none | buy |
| Avg. price target upside | -7.43% | +30.21% |
| Average volume | 441.70K | 354.36K |
| Shares outstanding | 30.93M | 38.09M |
| Employees | 226 | 1,438 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCEL has outperformed VMD by 102.2 percentage points over the past year.
About Avita Medical
RCEL stock →AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Health Care · Medical/Dental Instruments · 226 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Health Care · Misc Health and Biotechnology Services · 1,438 employees
RCEL vs VMD FAQ
Which is bigger, Avita Medical or Viemed Healthcare?
Avita Medical (RCEL) is larger, with a market capitalization of $401.89M compared with $365.65M for Viemed Healthcare (VMD).
Which stock has performed better over the past year, RCEL or VMD?
RCEL returned +138.57% over the past 12 months, compared with +36.39% for VMD (price return, excluding dividends). Past performance does not predict future results.
Are Avita Medical and Viemed Healthcare in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Avita Medical and Misc Health and Biotechnology Services for Viemed Healthcare.